Parexel sees modest quarterly growth as backlog rises by nearly $1bn

By Zachary Brennan

- Last updated on GMT

Parexel sees modest quarterly growth as backlog rises by nearly $1bn

Related tags Von rickenbach Revenue

Although Parexel’s consolidated service revenue increased by only 2% for the quarter, the company reported that its backlog included gross new business wins of $942.4m, which was 5.3% higher than the same quarter as last year.

CEO Josef von Rickenbach told investors Thursday: “We continue to be excited about the market opportunities that are in front of us, driven both by strategic partnerships and mid and small client companies, and we believe that we are well positioned to capitalize on them.”

Generally, von Rickenbach added, that the company saw “good RFP flow and bookings​,” though they were “tilted more to large companies and strategic partners – so far that seems to be the path in this calendar year​.”

On the more negative side, the company’s consulting segment experienced some client delays on a couple of large projects which negatively impacted quarterly revenue. The company also reported a slightly elevated level of cancellations of $289.7m, though von Rickenbach noted that they “were not performance-based​” and only related to two clients.

As far as employees added, von Rickenbach noted the “significant increases​” continue from the recent acquisition of Quantum Solutions India​, which will add 900 employees, and other GlaxoSmithKline employees​, which are “in anticipation of work moving through various stages of study startup and full production​.”

Analysts seemed lukewarm on the results and the stock price fell by about 7% Thursday. Still, Citi’s Garen Sarafian noted that the current quarter’s book to bill of 1.3 is the third highest over the last 11 quarters, and through the first three quarters of this FY, the company’s net book-to-bill is now 1.24, which is “well above its 1.14x average in Fiscal 2014 and particularly poor F1Q15’s 0.88x​.”

We expect that revenue growth in our Parexel Consulting business will be back on track in the fourth quarter on a sequential basis​,” von Rickenbach noted. “Revenue in our Clinical Research Services and Parexel Informatics businesses came in as we expected​.”

Moving forward, Parexel lowered its yearly revenue range expectations slightly, from $2.04 - $2.07bn to $2.012bn - $2.032bn.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us


View more